MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/03/6406-1463-1473$20.00
Mol Pharmacol 64:1463-1473, 2003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stonehouse, A. H.
Right arrow Articles by Jones, F. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stonehouse, A. H.
Right arrow Articles by Jones, F. S.

Caffeine Regulates Neuronal Expression of the Dopamine 2 Receptor Gene

Anthony H. Stonehouse, Megumi Adachi, Elisabeth C. Walcott , and Frederick S. Jones

The Neurosciences Institute, San Diego, California

The psychoactive drug caffeine influences neuronal physiology; however, it is unknown whether it can dynamically alter the expression of genes that influence neurotransmission. Here, we report that caffeine stimulates transcription of the dopamine 2 receptor (D2R) gene in PC-12 cells and primary striatal cultures and increases D2R protein expression in the striatum. Physiological doses of caffeine and the specific adenosine 2A receptor antagonist 8-(3-chlorostyryl) caffeine both increased the activity of a D2R/luciferase reporter construct within 24 h, and simultaneous treatment with 2-[p-(2-carboxyethyl)phenethylamino]-5'-N-ethylcarboxamidoadenosine (CGS 21680), a specific adenosine 2A receptor agonist, eliminated this effect. Tests of additional constructs revealed that specific regions of the D2R promoter (-117/-75) and 5'-untranslated region (+22/+317) were required for activation of D2R gene expression by caffeine. In primary striatal cultures, caffeine increased spontaneous firing of neurons between 12 and 80 min after treatment, whereas it increased D2R mRNA expression after only 4 h. These results indicate that regulation of D2R gene expression by caffeine occurs after the initial physiological response has subsided. In vivo, female mice treated with a dose of caffeine (50 mg/kg) showed 1.94- and 2.07-fold increases in D2R mRNA and protein expression, respectively. In contrast, male mice exhibited a 31% decrease in D2R mRNA expression and showed no changes in D2R protein expression. Collectively, these results demonstrate for the first time that caffeine alters D2R expression in neurons. They also suggest that caffeine consumption can lead to sexually dimorphic patterns of gene expression in the brain.


Received April 2, 2003; accepted August 19, 2003.

Address correspondence to: Dr. Anthony Stonehouse, The Neurosciences Institute, 10640 John Jay Hopkins Drive, San Diego, CA 92121. E-mail: stonehouse{at}nsi.edu




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Andretic, Y.-C. Kim, F. S. Jones, K.-A. Han, and R. J. Greenspan
Drosophila D1 dopamine receptor mediates caffeine-induced arousal
PNAS, December 23, 2008; 105(51): 20392 - 20397.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
F. S. Jones, J. Jing, A. H. Stonehouse, A. Stevens, and G. M. Edelman
Caffeine Stimulates Cytochrome Oxidase Expression and Activity in the Striatum in a Sexually Dimorphic Manner
Mol. Pharmacol., September 1, 2008; 74(3): 673 - 684.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
K. S. Kendler and R. J. Greenspan
The Nature of Genetic Influences on Behavior: Lessons From "Simpler" Organisms
Am J Psychiatry, October 1, 2006; 163(10): 1683 - 1694.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. A. Chappell, G. M. Edelman, and V. P. Mauro
Biochemical and functional analysis of a 9-nt RNA sequence that affects translation efficiency in eukaryotic cells
PNAS, June 29, 2004; 101(26): 9590 - 9594.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics